A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
- PMID: 23322546
- DOI: 10.1007/s40258-012-0008-7
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
Comment in
-
Authors' reply to Godman and Gustafsson: "A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing".Appl Health Econ Health Policy. 2013 Feb;11(1):83-4. doi: 10.1007/s40258-013-0009-1. Appl Health Econ Health Policy. 2013. PMID: 23359036 No abstract available.
Comment on
-
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.Appl Health Econ Health Policy. 2012 Jul 1;10(4):217-25. doi: 10.2165/11633930-000000000-00000. Appl Health Econ Health Policy. 2012. PMID: 22676213
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
